MEET OUR THOUGHT LEADERS

ISPOR 2018

We look forward to welcoming you in Baltimore at ISPOR 2018

Kantar Health is a leading exhibitor at ISPOR 2018 in Baltimore. Come visit us in the exhibition hall to engage with our experts at booth 202 to learn more about our new patient-centric research framework.

Join us for our podium presentation on Tuesday May 22, 5:00 PM - 5:15 PM

THE ASSOCIATION BETWEEN ANTI-EPILEPTIC DRUG ADHERENCE TO SODIUM CHANNEL BLOCKERS AND HEALTH-RELATED QUALITY OF LIFE: ANALYSIS OF US SURVEY DATA FROM PATIENTS WITH EPILEPSY  

+ There is limited research on the benefits of adhering to sodium channel blocker antiepileptic (SCB) treatments.

+ This study examined the relationship between SCB treatment adherence levels and health-related quality of life (HRQoL) among patients with epilepsy.

+ In this real-world assessment of patients with epilepsy on SCBs, high patient-reported adherence was associated with statistically and clinically meaningful HRQoL improvements compared with those with low/medium adherence.

Presenters:

+ Lee K Lee, Kantar Health, San Mateo, CA, USA,

+ Rajagopalan K, Sunovion Pharmaceuticals Inc., Marlborough, MA, USA

We will also be making several poster presentations on key topics. To find out more about our poster presentations, download the schedule below.

    kh_us_2018_ispor_email_wave_1_cover_v1

    kh_us_2018_ispor_email_wave_1_cta_v1                                              

Share